Normal view MARC view ISBD view

Complications in Percutaneous Dialysis Interventions: How to Avoid Them, and How to Treat Them When They do Occur. [electronic resource]

By:

Friedman, Tamir

Contributor(s):

Producer: 20170724Description: 58-64 p. digitalISSN:

1557-9808

Subject(s):

Online resources:

Available from publisher's website

In: Techniques in vascular and interventional radiology vol. 20

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article; Review

There are no comments on this title.

to post a comment.

Back to results

1 Prostatic carcinoma with lung metastases in a former bagasse worker; LH-RH analogs as an alternative therapy.
by Comaru-Schally, A M
2 Male contraception involving testosterone supplementation: possible increased risks of prostate cancer?
by Schally, A V
3 [Effects of cerebral, hypothalamic and hypophyseal peptides on the central nervous system].
by Comaru-Schally, A M
4 Hypothalamus and reproduction gonadotropin releasing hormone and its analogues clinical applications.
by Shally, A V
5 Present status of agonistic and antagonistic analogs of LH-RH in the treatment of advanced prostate cancer.
by Schally, A V
6 Potential use of analogs of luteinizing hormone-releasing hormones in the treatment of hormone-sensitive neoplasms.
by Schally, A V
7 Inhibition of prostate tumors by agonistic and antagonistic analogs of LH-RH.
by Schally, A V
8 Inhibition of the growth of some hormone dependent tumors by D-Trp6-LH-RH.
by Schally, A V
9 Antitumor effects of analogs of hypothalamic hormones in endocrine-dependent cancers.
by Schally, A V
10 Peptidergic appetite regulation.
by Medina-Santillán, R
11 Membrane receptors for peptides in experimental and human pancreatic cancers.
by Fekete, M
12 Introduction of LHRH-antagonists into the treatment of gynaecological disorders.
by Reissmann, T
13 Suppression of androgen production by D-tryptophan-6-luteinizing hormone-releasing hormone in man.
by Tolis, G
14 Somatostatin analogue RC-160 and LH-RH antagonist SB-75 inhibit growth of MIA PaCa-2 human pancreatic cancer xenografts in nude mice.
by Radulovic, S
15 LHRH analogues and breast cancer.
by Korkut, E
16 Clearance of lung metastases of prostate carcinoma after treatment with LH-RH agonist.
by Comaru-Schally, A M
17 Failure to interrupt established pregnancy in humans by D-tryptophan-6-luteinizing hormone-releasing hormone.
by Tolis, G
18 Inhibition of growth of experimental prostate cancer with sustained delivery systems (microcapsules and microgranules) of the luteinizing hormone-releasing hormone antagonist SB-75.
by Korkut, E
19 Efficacy and safety of luteinizing hormone-releasing hormone antagonist cetrorelix in the treatment of symptomatic benign prostatic hyperplasia.
by Comaru-Schally, A M
20 New approaches to therapy of cancers of the stomach, colon and pancreas based on peptide analogs.
by Schally, A V